Sandimmun, Infusionskonzentrat

7680449150301 CH-44915 Infusionskonzentrat
Sandimmun, Infusionskonzentrat
Sandimmun, Infusionskonzentrat
Sandimmun, Infusionskonzentrat
1 / 3
google

Article details

Package size
10 x 1
Selling units
10
Measure
ml
Galenic form
Infusionskonzentrat
Galenic group
Lösbar zur Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/05/2025
Summary of Product Characteristics
Français
29/05/2025
Summary of Product Characteristics
Italien
29/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
650.0 MG Substance HPADK
(N/A)
261.0 MG Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 46.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1997

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
44915
Drug name
Sandimmun, Infusionskonzentrat
Galenic form
KOPA
ATC Code
L04AD01
Authorization status
Z
Dispensing category
B
First authorization
28/12/1982
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Immunsuppressivum

Package details

Description (FR)
SANDIMMUN conc perf 50 mg/ml 10 amp 1 ml
Description (DE)
SANDIMMUN Inf Konz 50 mg/ml 10 Amp 1 ml
Market launch
28/12/1982
Narcotic (BTM)
No

Other package sizes (1)

SANDIMMUN conc perf 250 mg/5ml 10 amp 5 ml
10 x 5 ML
GTIN: 7680449150141
View